Autoimmune Disease Diagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Autoimmune Disease Diagnostics Market
1.1. Definition and Scope
1.1.1. Definition of Autoimmune Disease Diagnostics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Autoimmune Disease Diagnostics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Autoimmune Disease Diagnostics Market By Product
1.2.3. Autoimmune Disease Diagnostics Market By Test Type
1.2.4. Autoimmune Disease Diagnostics Market By End-Use
1.2.5. Autoimmune Disease Diagnostics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Autoimmune Disease Diagnostics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Autoimmune Disease Diagnostics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Autoimmune Disease Diagnostics Market By Product
4.1. Introduction
4.2. Autoimmune Disease Diagnostics Market Revenue By Product
4.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By Product, 2018-2030
4.2.2. Systemic
4.2.2.1. Systemic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Rheumatoid Arthritis
4.2.2.2.1. Rheumatoid Arthritis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Systemic Lupus Erythematosus (SLE)
4.2.2.3.1. Systemic Lupus Erythematosus (SLE) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.4. Psoriasis
4.2.2.4.1. Psoriasis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.5. Multiple Sclerosis
4.2.2.5.1. Multiple Sclerosis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.6. Others
4.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Localized
4.2.3.1. Localized Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.2. Inflammatory Bowel Disease
4.2.3.2.1. Inflammatory Bowel Disease Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.3. Type 1 Diabetes
4.2.3.3.1. Type 1 Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.4. Thyroid
4.2.3.4.1. Thyroid Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.5. Others
4.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Autoimmune Disease Diagnostics Market By Test Type
5.1. Introduction
5.2. Autoimmune Disease Diagnostics Market Revenue By Test Type
5.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By Test Type, 2018-2030
5.2.2. Antinuclear Antibody Tests
5.2.2.1. Antinuclear Antibody Tests Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. C-reactive Protein (CRP)
5.2.3.1. C-reactive Protein (CRP) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Autoantibody Tests
5.2.4.1. Autoantibody Tests Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Complete Blood Count (CBC)
5.2.5.1. Complete Blood Count (CBC) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Urinalysis
5.2.6.1. Urinalysis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Autoimmune Disease Diagnostics Market By End-Use
6.1. Introduction
6.2. Autoimmune Disease Diagnostics Market Revenue By End-Use
6.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Diagnostics Centers
6.2.3.1. Diagnostics Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Autoimmune Disease Diagnostics Market By Country
7.1. North America Autoimmune Disease Diagnostics Market Overview
7.2. U.S.
7.2.1. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
7.2.2. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
7.2.3. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
7.3.2. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
7.3.3. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Autoimmune Disease Diagnostics Market By Country
8.1. Europe Autoimmune Disease Diagnostics Market Overview
8.2. U.K.
8.2.1. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.2.2. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.2.3. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.3.2. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.3.3. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.4.2. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.4.3. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.5.2. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.5.3. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.6.2. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.6.3. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia-Pacific Autoimmune Disease Diagnostics Market By Country
9.1. Asia-Pacific Autoimmune Disease Diagnostics Market Overview
9.2. China
9.2.1. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.2.3. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.3.3. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.4.2. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.4.3. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.5.2. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.5.3. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5.4. 2030
9.6. South Korea
9.6.1. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.6.2. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.6.3. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.7.2. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.7.3. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.8. Asia-Pacific PEST Analysis
CHAPTER 10. Latin America Autoimmune Disease Diagnostics Market By Country
10.1. Latin America Autoimmune Disease Diagnostics Market Overview
10.2. Brazil
10.2.1. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.2.3. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.3.3. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.4.3. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Autoimmune Disease Diagnostics Market By Country
11.1. Middle East & Africa Autoimmune Disease Diagnostics Market Overview
11.2. GCC
11.2.1. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.2.3. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.3.3. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.4.3. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Autoimmune Disease Diagnostics Market
12.1. Autoimmune Disease Diagnostics Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancement
12.2.3. Mergers And Acquisition In Global Autoimmune Disease Diagnostics Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Abbott Laboratories 2021 Autoimmune Disease Diagnostics Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AstraZeneca
13.3. Beckman Coulter Inc.
13.4. Bio-Rad Laboratories Inc.
13.5. F. Hoffmann-La Roche
13.6. Hemagen Diagnostics Inc.
13.7. Inova Diagnostics Inc.
13.8. Novartis AG
13.9. Pfizer Inc.
13.10. Sanofi-aventis
Frequently Asked Questions
What is the size of global autoimmune disease diagnostics market in 2021?
The market size of autoimmune disease diagnostics market in 2021 was accounted to be USD 4.4 Billion.
What is the CAGR of global autoimmune disease diagnostics market during forecast period of 2022 to 2030?
The projected CAGR of autoimmune disease diagnostics market during the analysis period of 2022 to 2030 is 7.2%.
Which are the key players operating in the market?
The prominent players of the global autoimmune disease diagnostics market include Abbott Laboratories, AstraZeneca, Beckman Coulter Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Hemagen Diagnostics Inc., Inova Diagnostics Inc., Novartis AG, Pfizer Inc., and Sanofi-aventis.
Which region held the dominating position in the global autoimmune disease diagnostics market?
Europe held the dominating autoimmune disease diagnostics during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for autoimmune disease diagnostics during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global autoimmune disease diagnostics market?
Growing prevalence of autoimmune disease, favorable government policies for research activities, and rising awareness regarding autoimmune disorders drives the growth of global autoimmune disease diagnostics market.
Which product held the maximum share in 2021?
Based on product, localized segment is expected to hold the maximum share of the autoimmune disease diagnostics market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
